Alzheimer Dementia (AD) Clinical Trial
Official title:
Investigating Genetic Status in Patients Presenting to Clinic
The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified. Further, in many patients, polygenic risk is thought to give rise to pathophysiologic changes, but which specific genes affect risk are largely yet unknown. By examining genotypes in patients that present to our Cognitive Neurology and Alzheimer's Research Clinic with suspected or confirmed neurodegenerative dementia, or have a history of a familial dementia, we aim to help identify and characterize genetic mutations or polymorphisms that give rise to neurodegenerative diseases.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02553928 -
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
|
Phase 4 | |
| Active, not recruiting |
NCT03672201 -
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
|
N/A | |
| Not yet recruiting |
NCT06330155 -
A Genetic Study for Alzheimer Dementia: Case-control Study
|
||
| Completed |
NCT04113967 -
Efficacy of a Biodanza Program in People With Alzheimer's Disease.
|
N/A | |
| Completed |
NCT03221296 -
Fall Prevention - Vestibular Rehabilitation
|
N/A | |
| Completed |
NCT03070821 -
Therapy of Alzheimer's Disease With Neurofeedback
|
N/A |